Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 30 citing Carroll: Control of postprandial hyperglycemia. (0.09 sec) 

Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1

- glucagon.com [PDF]  - Free from Publisher
MC Riddle, DJ Drucker - Diabetes Care, 2006 - Am Diabetes Assoc
Current therapies for type 2 diabetes are frequently associated with inadequate
control of postprandial hyperglycemia, weight gain, and, in the case of oral
agents, loss of efficacy over time. A better understanding of physiological ...
Cited by 71 - Related articles - BL Direct - All 10 versions

Repaglinide versus nateglinide monotherapy

- Free from Publisher
J Rosenstock, DR Hassman, RD Madder, SA … - Diabetes Care, 2004 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—Enrolled patients (n = 150) had received treatment
with diet and exercise in the previous 3 months with HbA 1c >7 and ≤12%.
Patients were randomized to receive monotherapy with repaglinide (n = 76) ...
Cited by 60 - Related articles - BL Direct - All 6 versions

Hypoglycemia as a barrier to glycemic control


S Davis, MD Alonso - Journal of Diabetes and its Complications, 2004 - Elsevier
Diabetes mellitus is associated with significant morbidity and mortality derived
from long-term microvascular and macrovascular complications of chronic
hyperglycemia. The Diabetes Control and Complications Trial (DCCT) and the ...
Cited by 58 - Related articles - All 12 versions

Current therapeutic options in type 2 diabetes mellitus: a practical approach

- nih.gov
MT Sheehan - Clinical Medicine & Research, 2003 - Marshfield Clinic
The incidence of type 2 diabetes mellitus (DM) in the United States continues to
grow rapidly, paralleling the overweight and obesity epidemic. For many years
the only therapeutic options for type 2 DM were sulfonylureas and insulin. ...
Cited by 43 - Related articles - All 9 versions

Caffeine impairs glucose metabolism in type 2 diabetes

- Free from Publisher
JD Lane, CE Barkauskas, RS Surwit, MN … - Diabetes Care, 2004 - Am Diabetes Assoc
Caffeine is a widely used drug despite evidence that it has deleterious
consequences for health, including diabetes (1). In 1967, a study reported that
drinking two cups of instant coffee significantly impaired glucose ...
Cited by 36 - Related articles - BL Direct - All 5 versions

Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type …


MF Carroll, A Gutierrez, M Castro, D … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc
This study was designed to compare the efficacy of three insulinotropic agents
in the control of postprandial hyperglycemia in type 2 diabetes. Fifteen
subjects with noninsulin-requiring type 2 diabetes were admitted to the ...
Cited by 27 - Related articles - BL Direct - All 6 versions

Drug therapy of diabetes in the elderly


R Oiknine, AD Mooradian - Biomedicine & Pharmacotherapy, 2003 - Elsevier
The prevalence of type 2 diabetes mellitus is increasing in the elderly.
Although type 1 diabetic patients are living longer, over 95% of elderly people
affected with diabetes have type 2 diabetes. This segment of the ...
Cited by 18 - Related articles - All 5 versions

Nateglinide-current and future role in the treatment of patients with type 2 diabetes mellitus


IW Campbell - International Journal of Clinical Practice, 2005 - medscape.com
Therapy for type 2 diabetes mellitus should aim to control not only fasting, but
also postprandial glucose levels. Nateglinide, a d-phenylalanine derivative,
restores postprandial early phase insulin secretion in a transient and ...
Cited by 15 - Related articles - BL Direct - All 6 versions

Nateglinide alone or with metformin safely improves glycaemia to target in patients up to an …


JU Weaver, D Robertson, SL Atkin - Diabetes, Obesity and Metabolism, 2004 - ingentaconnect.com
IngentaConnect. ...
Cited by 11 - Related articles - BL Direct - All 2 versions

Acute inhibition of inducible nitric oxide synthase but not its absence suppresses asthma- …

- pasteur.ac.ir [PDF] 
RG Landgraf, M Russo, S Jancar - European journal of pharmacology, 2005 - Elsevier
In the present study we investigated the lymphocytes infiltration and other
parameters of allergic lung inflammation comparing mice submitted to acute
suppression of nitric oxide synthesis with mice deficient in inducible ...
Cited by 10 - Related articles - All 4 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google